Expression and characterization of the trans-activator of HTLV-III/LAV virus
- PMID: 3490693
- DOI: 10.1126/science.3490693
Expression and characterization of the trans-activator of HTLV-III/LAV virus
Abstract
The human T-lymphotropic retrovirus HTLV-III/LAV encodes a trans-activator that increases viral gene expression. We expressed this trans-activator in animal cells and studied its structural and functional characteristics. The putative trans-activator protein was immunoprecipitated from overproducing stable cell lines and shown to migrate as a 14-kilodalton polypeptide on sodium dodecyl sulfate-polyacrylamide gels. S1 nuclease mapping experiments showed that the trans-activator increases the levels of steady-state messenger RNA transcribed from the viral long terminal repeat promoter. Sequences within the R region of the HTLV-III/LAV long terminal repeat are essential for trans-activation. Quantitations of messenger RNA and protein showed that the protein increase was greater than the messenger RNA increase in CV1 and HeLa cells, indicating that more than one mechanism was responsible for the trans-activation and that cell type-specific factors may determine the final level of trans-activation.
Similar articles
-
Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.Nature. 1986 Feb 13-19;319(6054):555-9. doi: 10.1038/319555a0. Nature. 1986. PMID: 3003584
-
Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.Nature. 1988 Oct 20;335(6192):738-40. doi: 10.1038/335738a0. Nature. 1988. PMID: 3262832
-
Expression of the art gene protein of human T-lymphotropic virus type III (HTLV-III/LAV) in bacteria.J Virol. 1987 Feb;61(2):633-7. doi: 10.1128/JVI.61.2.633-637.1987. J Virol. 1987. PMID: 3543401 Free PMC article.
-
Regulation of expression of human immunodeficiency virus.New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review.
-
Molecular biology of human T-lymphotropic retroviruses.Cancer Res. 1985 Sep;45(9 Suppl):4539s-4544s. Cancer Res. 1985. PMID: 2990683 Review.
Cited by
-
Transactivation of heterologous promoters by HIV-1 tat.Nucleic Acids Res. 1991 Dec;19(25):7225-9. doi: 10.1093/nar/19.25.7225. Nucleic Acids Res. 1991. PMID: 1662814 Free PMC article.
-
Chemical synthesis of biologically active tat trans-activating protein of human immunodeficiency virus type 1.J Virol. 1990 Jun;64(6):3074-7. doi: 10.1128/JVI.64.6.3074-3077.1990. J Virol. 1990. PMID: 2186178 Free PMC article.
-
Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.Proc Natl Acad Sci U S A. 1990 Sep;87(18):7030-4. doi: 10.1073/pnas.87.18.7030. Proc Natl Acad Sci U S A. 1990. PMID: 2205850 Free PMC article.
-
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.J Virol. 1988 Mar;62(3):673-9. doi: 10.1128/JVI.62.3.673-679.1988. J Virol. 1988. PMID: 2828663 Free PMC article.
-
AIDS and the obstetrician-gynecologist.J Natl Med Assoc. 1987 Oct;79(10):1057-67. J Natl Med Assoc. 1987. PMID: 3316672 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
